Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trialFriedrich Koehler, Karl Stangl, Kerstin Koehler et al.|The Lancet|2018Cited by 734
Digitoxin in Patients with Heart Failure and Reduced Ejection FractionUdo Bavendiek, Johann Bauersachs, Xiaofei Liu et al.|New England Journal of Medicine|2025Cited by 65
Mortality and morbidity 1 year after stopping a remote patient management intervention: extended follow-up results from the telemedical interventional management in patients with heart failure II (TIM-HF2) randomised trialFriedrich Koehler, Stefan D. Anker, Kerstin Koehler et al.|The Lancet Digital Health|2019Cited by 61
Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trialUdo Bavendiek, Johann Bauersachs, Anika Großhennig et al.|Clinical Research in Cardiology|2023Cited by 18